The high quality of induced pluripotent stem cells (iPSCs) has been determined to be high-grade chimeras that are competent for germline transmission, and viable mice can be generated through tetraploid complementation. Most of the high-quality iPSCs described to date have been male. Female iPSCs, especially fully pluripotent female iPSCs, are also essential for clinical applications and scientific research. Here, we show, for the first time, that a gender-mixed induction strategy could lead to a skewed sex ratio of iPSCs. After reprogramming, 50%, 70%, and 90% female initiating mouse embryonic fibroblasts at different male ratios resulted in 14.1 6 6.8% (P , 0.05), 31.8 6 5.4% (P , 0.05), and 80.1 6 2.8% (P , 0.05) female iPSCs, respectively. Furthermore, these female iPSCs had pluripotent properties typical of embryonic stem cells. Importantly, these fully pluripotent female iPSCs could generate viable mice by tetraploid complementation. These findings indicate that highquality female iPSCs could be derived effectively, and suggest that clinical application of female iPSCs is feasible.
INTRODUCTION
Pluripotent stem cells can be induced from somatic cells by a combination of several transcription factors [1] [2] [3] [4] [5] [6] or using chemicals alone [7] . Recently, studies have identified several chemicals involved in epigenetic modification that can improve the efficiency of induced pluripotent stem cells (iPSCs) generation [8] [9] [10] [11] [12] [13] . In addition, some iPSCs can attain true pluripotency and support the development of all-iPSC mice using tetraploid complementation, the most stringent assay for developmental potential. This generation of iPSCs has revolutionized the field of regenerative medicine and also provides a unique platform to study genetic diseases in vitro, because they are technically simple to generate and are ethically noncontroversial.
However, almost all currently available high-quality iPSC lines, as determined by germline transmission or tetraploid blastocyst complementation, are male [3, [14] [15] [16] [17] [18] [19] [20] . Most of these iPSCs were generated from gender-mixed somatic cells. Moreover, male bias has been observed in germline-competent embryonic stem (ES) cell (ESC) lines [21] . Thus, the phenomenon of aberrant sex ratio in iPSCs, and whether male somatic cells have an advantage over female cells during the reprogramming of gender-mixed somatic cells to pluripotency, is of great interest. Therefore, in the present study, we induced iPSCs from gender-mixed mouse embryonic fibroblasts (MEFs) at different initiating sex ratios, using a widely accepted iPSC generation system. During stem cell therapy for tissue regeneration, male and female neural stem cells exhibit intrinsic biological differences in the process of in vitro differentiation [22, 23] . Sexual dimorphism has been observed in muscle-derived and bone marrow stem cells, with female stem cell lines having a higher proliferation potential than male cell lines [24, 25] . Moreover, to establish animal models for X chromosome-linked human diseases, female iPSCs, especially high-quality female iPSCs, may be preferable for gene modification experiments because of the hemizygous nature of male iPSCs [21] . Therefore, we attempted to generate fully pluripotent female iPSCs, as determined by the production of all-iPSC mice.
MATERIALS AND METHODS

Mice and Cell Culture
MEFs were derived from 13.5-day postcoitum embryos collected from female OG2 (Oct4-GFP transgenic) mice mated with male Rosa26-M2rtTA transgenic mice. All of the animal procedures were performed according to the ethical guidelines of the National Institute of Biological Sciences and China Agricultural University. MEFs were cultured in fibroblast medium containing Dulbecco modified Eagle medium (DMEM; Gibco, Life Technologies) 4 These authors contributed equally to this work.
supplemented with 10% fetal bovine serum (FBS; Gibco), 1 mM glutamine, 1% nonessential amino acids, and 50 U/50 lg/ml penicillin/streptomycin (all Invitrogen, Life Technologies). ESCs and iPSCs were cultured on mitomycin C-treated female MEFs in ESC medium, comprised of DMEM supplemented with 15% FBS, 1 mM L-glutamine, 1% nonessential amino acids, 0.1 mM 2-mercaptoethanol, and 1000 U/ml leukemia inhibitory factor (LIF; all from Chemicon). The embryoid body differentiation medium was comprised of ESC growth medium without LIF.
Generation of iPSCs
The generation of iPSCs has been described previously [16, [26] [27] [28] [29] . Briefly, 293T cells were transfected with TetO-FUW-Oct4, Sox2, Klf4, and cMyc plasmids, separately, with lentivirus packaging plasmids ps-PAX-2 and pMD2G, using the Vigofect reagent (Vigorous Biotechnology). The medium was replaced 12 h after transfection, and the virus supernatants were harvested after an additional 48 h. MEFs were plated at 1 3 10 4 cells per well in six-well plates with filtered viral supernatant containing 5 lg/ml polybrene. The infection medium was replaced after 12 h with the ESC medium supplemented with 1 mg/L doxycycline (Dox). The medium was replaced every day until several ESC-like colonies that were positive for GFP appeared (around 12 days).The cells were then cultured for another 2-3 days with ES medium without Dox. Finally, the GFP-positive colonies were picked and cultured on mitomycin C-treated female MEFs.
Gender Determination of iPSCs
Initial mixed-sex MEFs were divided into three groups: 10% XY þ 90% XX (group 1), 30% XY þ 70% XX (group 2), and 50% XY þ 50% XX (group 3). After infection for approximately 14 days, the iPSC colonies that were positive for GFP were picked individually and placed into wells of a 96-well plate. These steps were repeated eight times, selecting a total of 768 iPSC colonies in each group, which were used for PCR determination of sex using primers specific for Sry, the sex-determining region of the Y chromosome, 5 0 -CATCGGAGGGCTAAAGTGTC-3 0 (forward) and 5 0 -TCCAGTCTTGCCTG TATGTG-3 0 (reverse). As a control, we used primers specific for b-actin, 5 0 -CTCAGCCACGCCCTTTCTCA-3 0 (forward) and 5 0 -GCTTTGTCACAC GAGCCATTGT-3 0 (reverse). Amplification conditions consisted of an initial denaturation at 958C for 3 min, followed by 35 cycles of denaturation at 958C for 30 sec, annealing at 608C for 30 sec, and extension at 728C for 30 sec, and a final extension at 728C for 5 min. PCR products were separated on 1.5% agarose/TAE gels, visualized by staining with ethidium bromide, and the images were analyzed using Quantity One analysis software (Bio-Rad Laboratories). To validate the PCR results, randomly selected iPSC colonies were assessed by fluorescent in situ hybridization (FISH), according to the manufacturer's instructions (Kreatech Diagnostics Inc., Amsterdam, The Netherlands). Briefly, adherent iPSCs on slides were immersed in 23 salinesodium citrate/0.5% igepal, pH 7.0, at 378C for 15 min, dehydrated in a gradient ethanol series, and incubated with XCyting mouse probes for the X (fluorescein isothiocyanate) and Y (Orange) chromosomes (MetaSystems), denatured at 758C for 3 min, and then incubated overnight at 378C. The slides were washed in wash buffer at room temperature without agitation. They were subsequently dehydrated in a gradient ethanol series, counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI), and observed by fluorescence microscopy. Chromosomal G-band analyses further confirmed the PCR and FISH results, and were performed at Peking University Third Hospital [16] .
Alkaline Phosphatase and Immunofluorescence Staining
Alkaline phosphatase (AP) staining was performed using an Alkaline Phosphatase Detection kit (Sigma-Aldrich Chemical Co.), according to the manufacturer's instructions. Induced PSCs on gelatin-coated cover slides were fixed in 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and blocked with 10% normal goat serum. The cells were subsequently incubated with primary antibodies against Oct4 (Santa Cruz Biotechnology), Nanog (Cosmo BioCo), and SSEA-1 (Abcam), washed three times, and incubated with appropriate secondary antibodies. All slides were subsequently counterstained with DAPI. The samples were viewed using an LSM 510 META microscope (Zeiss) and a Plan Neofluar 633/1.4 oil differential interference contrast objective.
RNA Extraction and RT-PCR
Total RNA was isolated from cell pellets using the TRIzol reagent (Invitrogen, Life Technologies), according to the manufacturer's instructions, and incubated with DNase I to remove any contaminating genomic DNA.
Isolated RNA was then used as a template for reverse transcription and PCR amplification, using previously described primers [16] .
Bisulfite Sequencing
Genomic DNA was isolated using a standard phenol:chloroform:isoamyl alcohol (25:24:1) protocol and treated with an EpiTeck Bisulfite Kit (Qiagen). The treated DNA samples were used as templates to amplify sequences at promoter regions, using previously described primers [16] . Two rounds of nested PCR were performed. The PCR products were cloned into the vector pEASY TM -T5 Zero (TransGen Biotech), and 10 randomly selected clones were sequenced.
In Vitro Differentiation of iPSCs
Single-cell preparations of iPSCs (5 3 10 4 /ml) were suspended in EB (embryoid body) medium without LIF and cultured for 2 days. Embryoid bodies were collected and pipetted into sterile ultralow-attachment six-well plates, where they were cultured for 6 days, changing the culture medium daily. The EBs were further differentiated by seeding them in 24-well gelatin-coated plates at 10-20 EBs per well and incubating in differentiation medium.
Teratoma Assay
Approximately 2-5 3 10 6 iPSCs were subcutaneously injected into the groin of severe combined immunodeficiency (SCID) mice. At 4 wk later, the animals were killed, and tumors were dissected and processed for hematoxylineosin staining and histopathological assessment.
Chimera Construction, Tetraploid Complementation, and Simple Sequence Length Polymorphism Analysis
To produce chimeric mice, 10-15 iPSCs were aggregated with eight-cell embryos. The embryos were cultured to blastocysts in potassium simplex optimized medium (KSOM; Millipore) and transferred to the uterine horns of E2.5 pseudopregnant mice. The generation of all-iPSC mice by tetraploid complementation was carried out as previously described [16] . In brief, tetraploid embryos were generated by the electrofusion of two-cell-stage embryos collected from mated female imprinting control region (ICR) mice. These tetraploid embryos were cultured in KSOM until they reached the blastocyst stage, after which 10-15 iPSCs were injected into the cavity of each tetraploid blastocyst. These tetraploid-complemented embryos were cultured in KSOM for 2-3 h and transplanted into the oviducts of E2.5 pseudopregnant ICR mice. The embryos were delivered by Cesarean section on Day 19.5 and the pups were fostered by lactating ICR mothers. The primer sequences for simple sequence length polymorphism (SSLP) analysis were obtained from the Mouse Genome Informatics website (http://www.informatics.jax.org).
Statistical Analysis
All data are expressed as mean 6 SD. Differences were evaluated using one-way ANOVA with the Statistical Package for the Social Sciences (SPSS) software (SPSS 11.5 for Windows). A P value , 0.05 was considered statistically significant.
RESULTS
Aberrant Sex Ratio in Mouse iPSCs
A review of previous study results showed that almost all currently available high-quality iPSC lines are male (Table 1) . To detect whether there are gender imbalances in mouse iPSCs, iPSCs were induced from MEF preparations with different sex ratios: 10% XY þ90% XX, 30% XY þ70% XX, and 50% XY þ50% XX (Fig. 1) . Following induction, the sex of GFPpositive single iPSC clones was determined by PCR using primers for the male-specific Sry gene; FISH and chromosomal G-band analyses were used to confirm the PCR results. A representative gender determination experiment is shown in Figure 2A . Assessment of 768 iPSC colonies generated from each of the MEF preparations showed that MEF preparations containing 10%, 30%, and 50% male cells yielded 19.9 6 2.8% (P , 0.05), 68.2 6 5.4% (P , 0.05), and 85.9 6 6.8% DI ET AL.
(P , 0.05) male iPSC colonies, respectively (Fig. 2B) . To test whether the growth status of MEFs resulted in the skewed sex ratio of male and female iPSC colonies, the growth statuses of male, female, and gender-mixed MEFs were determined when cultured in ES medium containing Dox, which is also the reprogramming medium. Their proliferation rates were comparable during the reprogramming process period (Fig. 2C) .
Female iPSCs Had the Same Characteristics as Typical ESCs
The pluripotencies of 10 female and 7 male iPSC lines were examined ( Table 2 ). Representative images of MEFs being induced to form iPSCs are shown in Figure 3A (left). A gradual loss of cells was observed after Dox addition, with iPSC colonies formed by Day 10 (Fig. 3A, right) . Single iPSC colonies were picked and cultured in ESC medium: all iPSC colonies were GFP positive, and showed normal ESC-like morphology (Fig. 3B ) and typical AP activity. A representative image of AP-stained female iPSC colonies is shown in Figure  3C .
The pluripotency of these cell lines was determined by assaying the expression of pluripotency-associated genes. RT-PCR analysis demonstrated that Oct4, Sox2, and Nanog mRNAs were expressed at comparable levels in female iPSCs, male iPSCs, and control ESC lines, but differed from the levels expressed in MEFs (Fig. 3D) . The levels of expression of Oct4, Sox2, and Nanog proteins, as well as the cell-surface marker SSEA-1, were also assayed in these cells using immunohistochemistry (Fig. 3E) . Bisulfite genomic DNA sequencing showed that the Oct4 and Nanog promoters were highly unmethylated in the female iPSC line XX-1 and the male iPSC line XY-2, but were highly methylated in the parental MEF cells (Fig. 3F) .
To further investigate the potential development of female iPSCs, we performed in vitro differentiation, teratoma, and chimera formation experiments. Female iPSCs formed embryoid bodies efficiently in vitro and started to differentiate spontaneously after replating onto gelatin-coated plates (Fig.  4A) . Using a teratoma assay to assess the pluripotency of female iPSCs in vivo, we observed teratomas containing all three germ layers (neural tube tissue, columnar epithelia and skeletal muscle, and glands) after injection of iPSCs into SCID mice (Fig. 4B) . Viable chimeric mice, as shown by their coat color, were generated by aggregating iPSCs with eight-cell ICR embryos, and transferring the aggregated embryos into pseudopregnant ICR recipient females (Fig. 4C) . In addition, mating of female chimeric mice with male ICR mice confirmed the successful germline transmission in the chimeras generated from female iPSCs (Fig. 4D) .
Female iPSCs Have True Pluripotency
We also tested whether female iPSCs could produce viable fertile mice through tetraploid complementation, considered to be the most stringent test for full pluripotency. Eight female iPSC lines that produced chimeras were chosen for tetraploid complementation (Table 2) , and the development of live mice 
GENERATION OF FULLY PLURIPOTENT FEMALE iPSCs
from these tetraploid-complemented embryos was determined. Two female all-iPSC mice were generated from the female iPSC line XX-1 (Fig. 4E) . Furthermore, SSLP, used to confirm that these all-iPSC mice differed from ICR mice at markers consistent with a C57 lineage or an OG2-rtTA origin, showed that these female iPSCs could attain true pluripotency (Fig.  4F) . Thus, we analyzed the full pluripotency state of several female iPSC lines by tetraploid complementation assays (Table   FIG. 2. Aberrant sex ratio in mouse iPSCs. A) Representative images showing the verification of sex determination of iPSCs generated from 50% XX cells. The genders of iPSCs were identified by PCR using primers for the male-specific Sry gene, with b-actin as a control. FISH was also performed to determine the gender of iPSC. Cells were hybridized with DNA probes specific for the X (green) and Y (red) chromosomes. Chromosomal G-band analyses further confirmed the PCR and FISH results. B) Effect of sex ratio of MEFs on the sex ratio of iPSCs. MEFs containing 10%, 30%, and 50% XY cells were used to generate iPSCs. These experiments were repeated eight times, with sex being determined for 768 iPSC colonies in each group: 1) MEFs containing 10% male cells generated 19.9 6 2.8% XY iPSC (P , 0.05); 2) MEFs containing 30% male cells generated 68.2 6 5.4% XY iPSC (P , 0.05); and 3) MEFs containing 50% male cells generated 85.9 6 6.8% XY iPSC (P , 0.05). C) Proliferation of male, female, and gender-mixed MEFs in the reprogramming medium (ES medium þ Dox).
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2). However, it was found that only one female iPSC line was capable of generating all-iPSC mice among the 10 female iPSC lines. Similarly, only one male iPSC line was capable of generating all-iPSC mice among the seven male iPSC lines. This low efficiency is comparable with those of previous studies [15] .
DISCUSSION
Our results showed that a gender-mixed strategy led to a skewed sex ratio of mouse iPSCs. We found that reprogramming of mixed male and female MEFs containing 10%, 30%, and 50% male cells yielded 19.9 6 2.8%, 68.2 6 5.4%, and 85.9 6 6.8% male iPSC colonies. Thus, fully pluripotent female iPSCs are more difficult to generate than male iPSCs, which agrees with previous findings of a male bias in germlinecompetent mouse ESC lines [21] .
These findings suggest that there were more obstacles in generating female compared with male iPSCs during reprogramming of mixed male and female MEFs. The generation of iPSCs is a long and complex process that involves downregulation of Thy1 and subsequent upregulation of SSEA-1 as early events, and the reactivation of the pluripotency circuitry, telomerase activity, and remodeling of chromatin as late events [30] [31] [32] [33] . In addition, the silenced X chromosome in female cells must be reactivated at a later stage in the reprogramming process, after endogenous pluripotency genes, including Oct4, Sox2, and Nanog, have been activated [34] [35] [36] . Previous studies showed that a rapid transition to fully reprogrammed iPSCs is accompanied by reactivation of the X chromosome from the pre-iPSCs that are trapped in an intermediate state of reprogramming [26, 30, 32] . Moreover, X reactivation also requires multiple steps, including Xist downregulation, H3K27me3 removal, and demethylation of X-linked genes. The characteristic signs of the process are downregulation of Xist expression, followed by loss of the accumulation of Polycomb proteins Ezh2 and Eed, and their associated histone H3K27me3 [37] . Thus, female somatic cells must overcome more obstacles than male somatic cells to convert to pluripotency, and reprogramming may take longer than in males [33, [38] [39] [40] [41] [42] [43] . This X reactivation of female somatic cells late in the reprogramming process might result in a lower percentage of female somatic cells in mixed MEFs undergoing reprogramming to iPSCs, which may be responsible, at least in part, for the gender imbalance in resultant iPSCs [44] . In addition, cells taken from male and female mice at Day 10.5 respond differently to applied stressors and show differential gene expression [45] , suggesting that a similar stress exists in mixed MEFs, with male cells dominating the reprogramming progress. However, the exact mechanisms underlying the aberrant sex ratio in iPSCs require further study.
Most importantly, previous studies showed that all highquality iPSCs that produced viable mice through tetraploid complementation were male [3, [14] [15] [16] [17] [18] [19] [20] . There are two possible explanations for the failure to obtain female all-iPSC mice in previous studies. First, a gender-mixed somatic cell strategy has been commonly used in the field of iPSC induction. This strategy may lead to fewer female iPSCs than male iPSCs being obtained, because the rare female iPSCs may not be finally established for the tetraploid complementation assay. Second, the efficiency of all-iPSC mice is always very low [15, 29] , and the rare female iPSCs may not be of sufficient quality to support the full-term development of all-iPSC mice. We were, however, able to generate several female iPSC lines that demonstrated features typical of ESCs, and one of these female iPSC lines was capable of generating viable all-iPSC mice. To The extent of chimerism was estimated on the basis of coat color. DI ET AL.
GENERATION OF FULLY PLURIPOTENT FEMALE iPSCs
the best of our knowledge, this study is the first to show definitive evidence that fully pluripotent female iPSCs could be generated by reprogramming female MEFs. These cell lines should provide a powerful tool for studies of lethal mutations in genes located on the X chromosome [21] , as well as for determining the processes that differentiate male and female cells [46] . Our study may also promote the implementation of the rules for separating out male and female cells out and then performing the experiments [46] .
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